DGS Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
DGS Capital Management's ELV Position: Q1 2026 in Review
DGS Capital Management reduced its Elevance Health (ELV) stake by 3.4% in Q1 2026, selling an estimated $34.8K and leaving 2,980 shares worth $872K. The position accounts for 0.14% of the portfolio, ranked #137.
DGS Capital Management first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.43M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- DGS Capital Management held 2,980 shares of Elevance Health worth $872K as of Q1 2026.
- DGS Capital Management sold 106 Elevance Health shares in Q1 2026, an estimated $34.8K.
- Elevance Health made up 0.14% of DGS Capital Management's portfolio in Q1 2026, its #137 holding.
- DGS Capital Management first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
- DGS Capital Management's Elevance Health position peaked at $1.43M in Q2 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.